Novo Nordisk A/S (NYSE:NVO)

54.75
Delayed Data
As of 3:59pm ET
 -0.43 / -0.78%
Today’s Change
41.72
Today|||52-Week Range
58.21
+29.37%
Year-to-Date

Today’s Trading

Previous close55.18
Today’s open54.55
Day’s range54.47 - 55.20
Volume641,981
Average volume (3 months)1,315,012
Market cap$110.7B
Dividend yield1.39%
Data as of 3:59pm ET, 07/06/2015

Growth & Valuation

Earnings growth (last year)+6.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+14.60%
Revenue growth (last year)+5.60%
P/E ratio4.8
Price/Sales7.07
Price/Book21.85

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.02+0.03%
ABBVAbbVie-0.04-0.06%
GSKGlaxoSmithKline-0.30-0.71%
LLYEli Lilly and Co+0.14+0.16%
Data as of 3:59pm ET, 07/06/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$0.47
Annual revenue (last year)$15.7B
Annual profit (last year)$4.7B
Net profit margin29.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Gladsaxe, Capital Region

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers